Vaughan David Investments INC Stake in Johnson & Johnson (JNJ) Increased

May 16, 2018 - By Nicole Mills

Johnson & Johnson (NYSE:JNJ) Corporate LogoBig Money Sentiment increased to 0.87 in 2017 Q4. It has change of 0.04, from 2017Q3’s 0.83. The ratio improved due to JNJ positioning: 35 sold and 884 reduced. 143 funds took holdings and 654 increased holdings. Investors holded 1.71 billion in 2017Q3 but now own 1.72 billion shares or 0.40% more. Sns Fin Grp Ltd Liability Co has invested 0.57% in Johnson & Johnson (NYSE:JNJ). Brown Cap Mgmt Ltd stated it has 2,437 shs. Bluemountain Capital Mgmt Ltd Co holds 24,192 shs. Denver Investment Advsrs Limited Com holds 57,975 shs or 0.4% of its capital. Lbmc Invest Advsrs Ltd, Tennessee-based fund reported 4,123 shs. Carnegie Cap Asset Management Ltd Limited Liability Company, a Ohio-based fund reported 112,769 shs. Northstar Investment Ltd Liability accumulated 96,540 shs or 2.44% of the stock. Moreover, Two Sigma Ltd Limited Liability Company has 0.01% invested in Johnson & Johnson (NYSE:JNJ). One Management Limited Liability Corp, California-based fund reported 26,052 shs. Swift Run Capital Management Ltd holds 2,914 shs. Montgomery Mgmt Inc owns 29,030 shs. Sivik Health Ltd Co stated it has 30,000 shs. Lvw Advsr Lc holds 26,058 shs. Ramsay Stattman Vela Price holds 3.75% in Johnson & Johnson (NYSE:JNJ) or 67,859 shs. Usa Finance Portformulas invested 0.58% of its capital in Johnson & Johnson (NYSE:JNJ).

JNJ had 1 sale and 0 insider purchases since February 15, 2018. This’s net activity of $20.17 million.

In 2017Q4 Securities and Exchange form is reported Vaughan David Investments Inc’s stake in Johnson & Johnson (JNJ) which was rose by 63.99%. 112,372 shares were bought by Vaughan David Investments Inc as the company’s stock declined 9.21% with the market. The institutional investor is holding 287,975 shares, compared to the 175,603 from the previous quarter. And the announced value of the major pharmaceuticals company is $40.24 million for the 2017Q4. $336.53 billion is the market cap of Johnson & Johnson. JNJ is touching $125.47 during the last trading session, after increased 0.27%.Currently Johnson & Johnson is uptrending after 1.12% change in last May 16, 2017. JNJ has 2.25M shares volume. JNJ underperformed the S&P 500 by 10.43%.

About $1.81B and $2.16B US Long portfolio Vaughan David Investments Inc manages. It reduced its stake in Vanguard Extended Market Etf (VXF) by 338,142 shares to 2,169 shares, valued at $242,000 in 2017Q4, according to the filing. Vaughan David Investments Inc has cut its stake in Walgreens Boots Alliance Inc and also reduced its holding in General Mills Inc (NYSE:GIS) by 65,038 shares in the quarter, for a total of 395,466 shares.

For more Johnson & Johnson (NYSE:JNJ) news posted recently go to:,,, or The titles are as follows: “Johnson & Johnson Stock Looks Attractive on the Big Dip” posted on May 10, 2018, “Johnson & Johnson (NYSE:JNJ) Stock Oversold” on May 03, 2018, “What Can I Expect To Make If I Invest In Johnson & Johnson Today?” with a publish date: May 16, 2018, “Johnson & Johnson: Waiting On The Wave” and the last “More states sue over opioid epidemic” with publication date: May 16, 2018.

Johnson & Johnson (NYSE:JNJ) Ratings Coverage

Total analysts of 10 have positions in Johnson & Johnson (NYSE:JNJ) as follows: 5 rated it a “Buy”, 1 with “Sell” and 4 with “Hold”. The positive are 50%. Since January 2, 2018 according to StockzIntelligence Inc Johnson & Johnson has 17 analyst reports. On Friday, April 13 Jefferies maintained Johnson & Johnson (NYSE:JNJ) with “Buy” rating. On Wednesday, April 18 Leerink Swann maintained Johnson & Johnson (NYSE:JNJ) with “Buy” rating. On Friday, April 20 Credit Suisse maintained Johnson & Johnson (NYSE:JNJ) rating. Credit Suisse has “Outperform” rating and $151 target. On Tuesday, February 6 the stock of Johnson & Johnson (NYSE:JNJ) has “Buy” rating given by Wells Fargo. The stock rating was maintained by Jefferies with “Buy” on Monday, February 26. On Wednesday, April 18 the company was maintained by Stifel Nicolaus. On Tuesday, January 23 the rating was maintained by BTIG Research with “Sell”. On Tuesday, February 27 Citigroup maintained the shares of JNJ in report with “Neutral” rating. On Friday, March 23 the rating was maintained by Jefferies with “Buy”. On Tuesday, April 10 the stock has “Equal-Weight” rating by Morgan Stanley.

Johnson & Johnson (NYSE:JNJ) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: